Portfolio Company · Allegis Capital X

9MD

Healthcare technology platform.

Valuation As OfQ1 2026 · Mar 31, 2026

Initial Investment2025-05

Stage / SectorPre-Seed (SAFE) · Health Tech

Allegis Invested Cost

$2.0M

Across Allegis vehicles

Current Fair Value

$2.5M

Q1 2026 mark

Gross MOIC

1.27x

Fair value ÷ cost

Ownership

4.4%

Fully diluted

Fair Value Mark History

Enterprise Value Progression ($M)

As Of	EV	Cost	Fair Value	MOIC
May 2025	$45.0M	$2.0M	$2.0M	1.00x
Mar 2026	$75.0M	$2.0M	$2.0M	1.00x
Mar 2026	$75.0M	$2.0M	$2.5M	1.27x

Pre-revenue / revenue not yet reported — see metrics below.

Metric	Inv LTM	2021	2022	2023	2024	2025	2026E	LTM	NTM
GAAP Revenue ($M)	—	—	—	—	—	—	—	—	—
EBITDA ($M)	—	—	—	—	—	—	—	—	—
Cash ($M)	—	—	—	—	—	—	—	—	—
Debt ($M)	—	—	—	—	—	—	—	—	—
ARR ($M)	—	—	—	—	—	—	—	—	—

Investment-date LTM and current-year (E) revenue shown in green. Figures per Allegis valuation workpapers; unaudited.

Round	Date	Invested	Post-Money EV	Fully Diluted Shares
SAFE (No Discount, Cap $45M Pre)	—	—	$45.0M	—
Total Invested		$0.0M

Company-level priced rounds and convertibles. Allegis holds a minority preferred position; see ownership above.